$47.52
Price
$3.0B
Market Cap
—
P/E Ratio
14.8
Forward P/E
$-1.24
EPS (TTM)
—
Dividend Yield
$339M
Cash
$631M
Total Debt
62M
Shares Out
$18.61
$48.99
52-Week Range
Institutional Ownership of SEADRILL 2021 LTD
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Patient Capital Management|Samantha McLemore
|
2.1M | $71M | $38.07 | +0.02% |
Trading Activity for SEADRILL 2021 LTD
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| SELL | -7.9% | 2.1M | $71M | $30.97 | |
| 2025-Q3 | |||||
| BUY | +0.0% | 2.2M | $67M | $30.50 | |
| 2025-Q2 | |||||
| BUY | +13.0% | 2.2M | $59M | $23.79 | |
| SELL | EXIT | — | — | $23.79 | |
| 2025-Q1 | |||||
| BUY | +17.6% | 2.0M | $49M | $31.22 | |
| 2024-Q4 | |||||
| BUY | +63.5% | 1.7M | $65M | $39.03 | |
| BUY | NEW | 1.0M | $40M | $39.03 | |
| 2024-Q3 | |||||
| BUY | +13.0% | 1.0M | $41M | $44.57 | |
| 2024-Q2 | |||||
| BUY | +0.8% | 907.6K | $47M | $50.74 | |
| 2024-Q1 | |||||
| BUY | +35.9% | 900.3K | $45M | $44.72 | |
| 2023-Q4 | |||||
| BUY | NEW | 662.6K | $31M | $42.05 | |
Insider Trading for SEADRILL 2021 LTD
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.